The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
PITTSBURGH--(BUSINESS WIRE)--ECM Therapeutics, a clinical stage regenerative medicine company pioneering the development of Extracellular Matrix-based therapeutics for the treatment of unmet medical ...
Morning Overview on MSN
Researchers think they’ve found a path to restoring human vision
For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...
Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness worldwide; however, effective treatments for optic nerve ...
Traditional mammalian models, including mice, hinder optic nerve regeneration research due to poor regenerative capacity, embryonic opacity, complex anatomy, and labor-intensive tissue processing. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback